Comparative study of efficacy of dopaminergic neuron differentiation between embryonic stem cell and protein-based induced pluripotent stem cell.
In patients with Parkinson's disease (PD), stem cells can serve as therapeutic agents to restore or regenerate injured nervous system. Here, we differentiated two types of stem cells; mouse embryonic stem cells (mESCs) and protein-based iPS cells (P-iPSCs) generated by non-viral methods, into m...
Main Authors: | Yoo-Wook Kwon, Yeon-Ju Chung, Joonoh Kim, Ho-Jae Lee, Jihwan Park, Tae-Young Roh, Hyun-Jai Cho, Chang-Hwan Yoon, Bon-Kwon Koo, Hyo-Soo Kim |
---|---|
Format: | Article |
Language: | English |
Published: |
Public Library of Science (PLoS)
2014-01-01
|
Series: | PLoS ONE |
Online Access: | http://europepmc.org/articles/PMC3899054?pdf=render |
Similar Items
-
Identification of the early and late responder genes during the generation of induced pluripotent stem cells from mouse fibroblasts.
by: Jihwan Park, et al.
Published: (2017-01-01) -
Dichotomous role of Shp2 for naïve and primed pluripotency maintenance in embryonic stem cells
by: Seong-Min Kim, et al.
Published: (2022-07-01) -
Pluripotency and differentiation of embryonic stem cells
by: Liu Yinyin, et al.
Published: (2020-01-01) -
Pluripotent Stem Cell Therapies for Parkinson Disease: Present Challenges and Future Opportunities
by: Tae Wan Kim, et al.
Published: (2020-08-01) -
Technical advances in pluripotent stem cell-derived and tumorigenic organoids
by: Suwon Kang, et al.
Published: (2022-08-01)